VivoSim Labs, Inc. Retained Earnings
VivoSim Labs, Inc. (VIVS) had Retained Earnings of -$357.34 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$357.34M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$356.00M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$350.24M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$347.55M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$357.34M 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$356.00M 10-Q · filed 2026-08-12 |
| 2025-12-31 | -$350.24M 10-Q · filed 2026-02-11 |
| 2025-09-30 | -$347.55M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$345.00M 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$342.16M 10-K · filed 2026-07-14 |
| 2024-12-31 | -$349.01M 10-Q · filed 2025-02-19 |
| 2024-09-30 | -$345.56M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$343.01M 10-Q · filed 2024-08-05 |
| 2024-03-31 | -$339.67M 10-K · filed 2025-06-05 |
| 2023-12-31 | -$336.62M 10-Q · filed 2024-02-08 |
| 2023-09-30 | -$333.02M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$329.03M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$325.00M 10-K · filed 2024-05-31 |
| 2022-12-31 | -$317.54M 10-Q · filed 2023-02-09 |
| 2022-09-30 | -$314.27M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$310.95M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$307.74M 10-K · filed 2023-07-14 |
| 2021-12-31 | -$305.83M 10-Q · filed 2022-02-14 |
| 2021-09-30 | -$302.33M 10-Q · filed 2021-11-08 |
| 2021-06-30 | -$298.82M 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$296.29M 10-K · filed 2022-06-10 |
| 2020-12-31 | -$293.69M 10-Q · filed 2021-02-08 |
| 2020-09-30 | -$291.18M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$282.23M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$279.46M 10-K · filed 2021-06-15 |
| 2019-12-31 | -$276.74M 10-Q · filed 2020-02-10 |
| 2019-09-30 | -$273.37M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$267.08M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$260.75M 10-K · filed 2020-05-28 |
| 2018-12-31 | -$253.77M 10-Q · filed 2019-02-07 |
| 2018-09-30 | -$247.37M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$241.54M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$234.12M 10-K · filed 2019-06-03 |
| 2017-12-31 | -$226.67M 10-Q · filed 2018-02-08 |
| 2017-09-30 | -$218.88M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$209.42M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$199.32M 10-K · filed 2018-05-31 |
| 2016-12-31 | -$188.66M 10-Q · filed 2017-02-09 |
| 2016-09-30 | -$179.08M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$169.64M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$160.87M 10-K · filed 2017-06-07 |
| 2015-12-31 | -$152.50M 10-Q · filed 2016-02-08 |
| 2015-09-30 | -$142.04M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$130.79M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$122.30M 10-K · filed 2016-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |